Accepted Manuscript State of science: Choroidal thickness and systemic health Kara-Anne Tan, Preeti Gupta, Mopt, Aniruddha Agarwal, MD, Jay Chhablani, MS, Ching-Yu Cheng, PhD, Pearse A. Keane, FRCOphth, Rupesh Agrawal, FRCS PII:
S0039-6257(15)30010-2
DOI:
10.1016/j.survophthal.2016.02.007
Reference:
SOP 6629
To appear in:
Survey of Ophthalmology
Received Date: 27 June 2015 Revised Date:
28 February 2016
Accepted Date: 29 February 2016
Please cite this article as: Tan KA, Gupta P, Agarwal A, Chhablani J, Cheng CY, Keane PA, Agrawal R, State of science: Choroidal thickness and systemic health, Survey of Ophthalmology (2016), doi: 10.1016/j.survophthal.2016.02.007. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
ACCEPTED MANUSCRIPT
Title: State of science: Choroidal thickness and systemic health
Authors: Kara-Anne Tan,1* Preeti Gupta, Mopt,1,2* Aniruddha Agarwal, MD,3 Jay Chhablani,
RI PT
MS,4 Ching-Yu Cheng, PhD,2, 5, 6 Pearse A. Keane, FRCOphth,7 Rupesh Agrawal, FRCS,2, 5, 6
Affiliations:
: Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
2
: Singapore Eye Research Institute and Singapore National Eye Centre, Singapore
3
: Stanley M. Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, Nebraska,
M AN U
SC
1
USA
: L.V. Prasad Eye Institute, Hyderabad, Telangana, India
5
: Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of
TE D
4
EP
Singapore and National University Health System, Singapore
: Duke-NUS Graduate Medical School, Singapore
7
: Moorfields Eye Hospital, NHS Foundation Trust, London, UK
2
: Stanley M. Truhlsen Eye Institute, University of Nebraska Medical Center, Omaha, Nebraska.
AC C
6
1
ACCEPTED MANUSCRIPT
Address for Correspondence: Rupesh Agrawal, FRCS Consultant
RI PT
National healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore 308433
M AN U
Financial Support
SC
Email:
[email protected]
The authors have no financial disclosure/proprietary interest. No conflicting relationship exists
* Joint First Authors
TE D
for any author.
EP
Keywords: Choroidal thickness; systemic disease; vascular layer; EDI-OCT; age; diurnal
AC C
variation; physiological; metabolic; inflammatory
2
ACCEPTED MANUSCRIPT
ABSTRACT
The choroid is a highly vascular structure; therefore, a wide range of systemic conditions
RI PT
can affect it. Conversely, choroid health may also give us insight into systemic health. With the emergence of optical coherence tomography, there has been a surge in the research on choroidal thickness and factors affecting it. Studies regarding the effect of systemic health on the choroid
SC
have largely been in the form of cross-sectional, prospective, and case studies. We offer a
AC C
EP
TE D
M AN U
summary of recent findings on the topic.
3
ACCEPTED MANUSCRIPT
INTRODUCTION
The choroid is the most vascular layer of the eye and plays an instrumental role in the
RI PT
physiology of the eye and in the pathogenesis of various ocular diseases. Per unit weight, the choroid has the highest blood flow of any tissue in the body7 and is the vascular supply to the outer retina, retinal pigment epithelium (RPE), possibly a portion of the optic nerve44 and is the
SC
only source of metabolic exchange for the avascular fovea.80
M AN U
A structurally and functionally normal choroidal vasculature is essential for retinal function. Abnormal choroidal blood volume and/or compromised flow may result in photoreceptors dysfunction and death with resultant vision loss.16 Consequently, the choroid plays a vital role in the pathophysiology of many conditions, such as central serous
74
TE D
chorioretinopathy,27 choroidal neovascularization related to age-related macular degeneration,68, polypoidal choroidal vasculopathy,68, 74 multifocal choroiditis,55 angioid streaks,6 and high
myopia related chorioretinal atrophy.20 Additionally, the high flow of blood in the choroid
EP
predisposes it as a site for metastatic and embolic spread of tumors and infections.80 Basically, as a result of the vascular nature of the choroid, potentially any disease affecting vasculature could
AC C
also affect choroid health.
Quantitative assessment of the choroid has always been a challenging task with
conventional imaging modalities such as indocyanine green angiography and ultrasonography because of limited image resolution and repeatability.22, 43 Histological evaluation is difficult due to the lack of samples and may not be accurate owing to changes in the choroid after fixation; 4
ACCEPTED MANUSCRIPT
however, our understanding of the choroid has been vastly augmented in recent times since the introduction of imaging the choroid in vivo using enhanced depth imaging technique of optical
RI PT
coherence tomography (EDI-OCT).104
This innovation in technology has sparked a rise in the amount of research done with regards to choroidal thickness,71, 86, 104 which is measured on the EDI-OCT from the outer border
SC
of the retinal pigment epithelium (RPE), represented by a hyperreflective line, to the inner border of the supra-choroidal space, represented by a hyporeflective line. There is, however, only
M AN U
limited literature published on systemic diseases affecting choroidal health.10 Weconsolidate the current knowledge on the effects of systemic health on choroidal thickness and attempt to provide insights on how choroid thickness may be an indicator of systemic health. Infections and
TE D
diseases limited to the eye without any systemic involvement have been excluded.
1. PHYSIOLOGICAL CHANGES IN CHOROIDAL THICKNESS
EP
1.1. Diurnal Variation
AC C
There have been few studies determining the diurnal variation of choroidal thickness in healthy patients.17, 106, 109, 113 A prospective study conducted by Tan et al of 12 healthy volunteers studied the choroidal thickness over 2 separate days in 5 fixed, 2-hour intervals.106 This study revealed that there is a significant variation in choroidal thickness, with mean amplitude of 33.7±21.5 µm. A progressively decrease in choroidal thickness occurred from 9am till 5pm, with good reproducibility of the diurnal pattern between 2 visits. A study conducted in Japanese
5
ACCEPTED MANUSCRIPT
patients by Usui et al113 performed over a 24 hour period showed a similar decreasing trend in choroidal thickness from 9am to 6pm. The amplitude reported, 33.0±14.3 µm, was also similar to the reported values in Tan et al. In contrast, a study by Toyokawa et al109 on Japanese subjects
RI PT
showed a smaller mean amplitude of 20.3 µm, and an apparent increase in choroidal thickness from morning to evening. Current literature suggests that there is pattern of change of choroidal thickness, however, the exact pattern remains uncertain. Findings suggest that the time of
SC
measurements is important to consider when assessing choroidal thickness in clinical practice and in trials. A possible hypothesis is that diurnal variation occurs because of the circadian
M AN U
rhythm of hormonal changes affecting the blood supply of the body,67 reflected in the vascular supply of the choroid, influencing its thickness. Increased vascular supply from sympathetic over activity in the morning67 may be reflected in the vascularity of the choroid and hence results in a
1.2. Age-Related Changes
TE D
thicker choroid in the morning.
EP
Age is one of the biggest contributing factors to choroidal thickness (Figure 1).37, 102 Previous histologic studies have shown a decrease in vascular density, overall luminal area, and
AC C
diameter of the choriocapillaris with age.34, 87, 97 This leads to a decrease in physiological functions of the choroid, i.e. the ability of the choroid to provide sufficient levels of oxygen and other metabolites to the RPE and outer retina may decrease,104 contributing to the onset of many diseases in the elderly. Similar to histologic studies, age-related choroidal thinning in healthy eyes is confimed by numerous clinical studies.11, 37, 49, 70, 71, 91, 96 In healthy eyes, Margolis et al and Ikuno et al reported a decrease in choroidal thickness by 15.6 µm and 14 µm, respectively, 6
ACCEPTED MANUSCRIPT
for each decade of life.49, 71 Ding et al. reported that age-related thinning occurs only after age 60 .31 Barteselli et al. reported decrease in choroidal volume by 7.32% for every decade.11 There is
thickness and choroidal volume decreases with advancing age.42, 115
RI PT
an increasing data from recent population-based studies that indicates that both choroidal
A study84 involving 96 eyes from 48 healthy children (mean age of 6.7 years) and 54 eyes
SC
from 27 healthy adults (mean age of 30.7 years) analyzed the choroidal thickness of the 2 populations and found that choroidal thickness was significantly greater in adults than in
M AN U
children. Thus, it is essential that age be taken into consideration when choroidal thickness is evaluated; however no normogram with age existents, and it may be time to develop one.
TE D
1.3. Gender Differences
There are gender differences in the epidemiology of certain macular diseases. For example, a large number of studies have shown that central serous chorioretinopathy is more
EP
common in men, with a male-to-female ratios of up to 8:1.66 Several studies have reported gender differences in choroidal thickness or volume, for instance, Barteselli et al11 reported
AC C
males have a 7.4% greater choroidal volume than females. Two of the population-based studies, the Beijing Eye Study involving 3233 subjects and the Singapore Malay Eye Study involving 540 subjects, showed male gender to be significantly associated with thicker choroid after adjusting for relevant confounders such as age and axial length.115 Likewise, Li et al. reported that choroidal thickness was 18% higher in men than in women after accounting for age and axial length.65 Similarly many other studies in healthy subjects determined subfoveal choroidal 7
ACCEPTED MANUSCRIPT
thickness to be higher in men than in women.83, 110, 121 In contrast there are two studies that showed no statistically significant difference in choroidal thickness measurements between men and women;94, 96 however, as themajority of existing studies reporting thicker choroid in men
RI PT
than in women, gender differences should be considered when interpreting an EDI SD-OCT scan of the choroid. This difference in the thickness of the choroid between males and females might also explain the gender differences in the epidemiology of macular diseases. The difference in
SC
choroidal thickness in male and female may be explained by the higher basal sympathetic tone in
M AN U
females.23
1.4. Activity of the Sympathetic System
The tone of the sympathetic system may have an important bearing on the thickness of
TE D
the choroid. As described in the preceding sections, the basal tone of the sympathetic system may be responsible, at least in part, for physiological variations such as diurnal changes, and gender-based differences. Studies have shown that sympathetic innervation of the choroid may
EP
be a protective mechanism against over-perfusion in conditions with acute rise in systemic blood pressure.14 Experimental models have shown that stimulation of the cervical sympathetic chain
AC C
results in frequency-dependent vasoconstriction and reduction in choroidal blood flow.14 Adrenergic innervation of the choroid that originates from superior cervical ganglion has been also demonstrated in a chicken model.41 Similarly, in a pigeon model, stimulation of the parasympathetic Edinger-Westphal nucleus dramatically increased choroidal blood flow. Such findings were also confirmed using histology.35As the basal tone of the sympathetic system may
8
ACCEPTED MANUSCRIPT
have a significant role in maintaining the choroidal blood flow and thickness, various conditions
2. CHOROIDAL THICKNESS IN WOMEN
SC
2.1. Menstrual Cycle
RI PT
that affect the ocular sympathetic innervation may have a direct bearing on choroidal thickness.
Complex hormonal changes occur during the menstrual cycle, and these fluctuations can
M AN U
affect vascular physiology and cause hemodynamic changes during different phases of the cycle.76, 77 In order to assess the systemic hemodynamic changes via choroidal vascular changes, a single prospective study112 looked at 23 eyes of 23 women with regular menstrual cycles. This study showed that, compared to the early follicular and ovulatory phases, choroidal thickness
TE D
decreased significantly during the mid-luteal phase. Choroidal thickness reduced by 6.47% between the early follicular and mid-luteal phase. The difference in choroidal thickness between the early follicular phase and ovulatory phase was, however, not statistically significant, but
EP
suggests that the blood supply during this phases may result in fluctuation of choroidal vascularity and hence affecting the choroidal thickness. Hormonal changes in menstruation have
AC C
been associated with altered sympathetic outflow.78 The altered sympathetic outflow may affect choroidal flow, which is possibly reflected in choroidal thickness. These findings show that it may be important to consider menstrual phase of the woman when interpreting choroidal thickness measurements.
2.2. Pregnancy
9
ACCEPTED MANUSCRIPT
Many ocular changes may occur in pregnancy, including changes in vision, ocular blood flow,21 decrease in intraocular pressure,4, 46, 57 and an increase in central cornea thickness116 and curvature.46 Two studies from Atas et al8 and Sayin et al98 with 76 and 119 participants,
RI PT
respectively, similarly showed that the choroidal thickness was greater in normal pregnant women than in normal, non-pregnant women. A prospective study40 involving 90 healthy
pregnant women in their first, second, or third trimester and 30 non-pregnant healthy women
SC
compared the choroidal thickness in these 4 groups. There was increased choroidal thickness in women in the second trimester as compared to non-pregnant women. There was no significant
M AN U
difference of choroidal thickness among the other groups. This suggests that choroidal thickening can occur in the second trimester. A likely mechanism for this finding is the increase of pregnancy-related fluid retention in the choroid.8
TE D
2.3. Pre-eclampsia
Pre-eclampsia is an obstetrical complication characterized by placental ischemia and
EP
systemic inflammation and vascular changes that lead to widespread vasoconstriction and systemic hypertension and proteinuria.47 Patients with severe pre-eclampsia may have cerebral or
AC C
visual disturbances, pulmonary edema, impaired liver function, and thrombocytopenia. Approximately 40% of women with preeclampsia report subjective visual disturbances.93
Atas et al8 and Sayin et al98 studied the effect of preeclampsia on choroidal thickness and
found that the increase of choroidal thickness in pre-eclamptic patients was significantly less than in normal pregnant patients and was similar to the choroidal thickness in normal, non10
ACCEPTED MANUSCRIPT
pregnant women. A study38 was conducted based on 15 severe preeclampsia cases and 15 healthy subjects of matched ethnicity and parity. A reference group of 19 age-matched, nongravid normotensive women was also studied. Severe pre-eclampsia cases demonstrated greater
RI PT
mean choroidal thickness as compared to controls.
The difference in findings may be the result of the difference in severity of the pre-
SC
eclampsia. On one hand, increased vascular permeability may increase the choroidal volume and thickness due to vascular leakage. Whereas decrease in choroidal thickness among patients with
M AN U
pre-eclampsia may be to the result of the increased systemic vascular vasospasm .8 The exact mechanism resulting in decreased choroidal thickness due to vasospasm in preeclampsia is not understood . Increased systemic vasospasm may decrease choroidal blood flow, resulting in decreased choroidal thickness. Thus, choroidal thickness may be a useful tool to screen for pre-
TE D
eclampsia.
EP
3. CHOROIDAL THICKNESS IN METABOLIC DISEASES
AC C
3.1. Diabetes Mellitus
Diabetes mellitus is a vascular disease characterized by macrovascular and microvascular
abnormities. In diabetic eyes, in addition to changes in retinal circulation, alterations to the underlying choroidal vasculature also seems to play a vital role as studies on diabetic eyes have reported various abnormalities, including choroidal vascular degeneration, choroidal aneurysms, choroidal neovascularization, obstruction of the choriocapillaris, and increased tortuosity and
11
ACCEPTED MANUSCRIPT
narrowing of the choroidal vessels.16, 45, 75 Given that choroid is an integral part of the nutrient and oxygen exchange with the outer third of the retina82 and choroidal thickness is considered
structural changes in the choroid including choroidal thickness.
RI PT
proxy measure of choroidal blood flow, compromised choroidal circulation might lead to
Although various studies have reported choroidal thickness in patients with diabetes
SC
mellitus, the results have been somewhat contradictory. Vujosevic et al. did not find any
significant difference in the mean choroidal thickness between their controls and diabetic
M AN U
patients.114 Regatieri et al. reported similar choroidal thickness between their controls and nonproliferative diabetic retinopathy.90 Meanwhile, Esmaeelpour et al. and Querques et al. both showed that patients with diabetes mellitus had significantly thinner choroids than non-diabetics regardless of their diabetic retinopathy status.33, 85 In contrast, Kim et al. showed that early
TE D
diabetic retinopathy patients had thinner choroids compared to non-diabetics, but there was progressively thickeninh with increasing severity of diabetic retinopathy.60 Xu et al. in the Beijing Eye Study measured choroidal thickness in 246 subjects with diabetes mellitus and
EP
concluded subfoveal choroid to be thicker in those with diabetes, whereas the presence and stage of diabetic retinopathy were not associated with change in subfoveal choroidal thickness after
AC C
accounting for relevant confounders.120 Thus, the effect of diabetes on the choroid is still not clear. The general consensus is that diabetes causes a decrease in choroidal thickness; however, different ocular parameters need to be explored to understand the pathophysiology of diabetes mellitus in the choroid.
3.2. Hypercholesterolemia 12
ACCEPTED MANUSCRIPT
Because of itshigh blood flow, the choroid has been considered as a potential site for the atherosclerotic changes95 that occur in presence of hypercholesterolemia; however, to date there is only one study118 on the effect of hypercholesterolemia on choroidal thickness. Wong et al. did
RI PT
a cross-sectional observational study on 322 healthy eyes of 161 subjects (mean age 60 years) found subfoveal choroidal thickness to be significantly higher in subjects with
hypercholesterolemia (306 ± 111µm) than controls (258 ± 97µm). Thus, hypercholesterolemia
SC
might be an important factor to be taken into consideration when analyzing choroidal thickness;
M AN U
however, further studies are needed to confirm this association.
4. CHOROIDAL THICKNESS IN CARDIOVASCULAR DISEASES
TE D
4.1. Hypertension
Hypertension is a known cause of pathology in vascular systems in the heart, brain, kidneys, and eyes. Ocular changes in hypertension include retinal hemorrhages, cotton wool
EP
spots, intraretinal lipid accumulation, and vessel closure in the retinal capillaries and the choriocapillaris. Although both retinal and choroidal changes are observed in hypertension, the
AC C
mechanism of choroidal damage remains unknown. Ahn et al3 in 42 eyes with hypertensive retinopathy demonstrated significant increase in subfoveal choroidal thickness, possibly due to interstitial fluid accumulation in the choroid caused by choroidal permeability changes. Thus, hypertension may be considered as a potential determinant of the thickness of the choroid; however further prospective studies with a larger sample size and longer follow-up periods are needed to confirm this finding. 13
ACCEPTED MANUSCRIPT
5. CHOROIDAL THICKNESS IN RESPIRATORY DISEASES
RI PT
5.1. Smoking
Smoking, an important modifiable risk factor for many cardiovascular, respiratory, and other systemic diseases,119 is also a risk factor for ocular vascular diseases like hypertensive
SC
retinopathy, age-related macular degeneration, and anterior ischemic optic neuropathy.18, 19, 59 Smoking cause vascular alterations, including decrease in retinal and choroidal blood flow.58, 64, Since smoking influences choroidal vasculature, this in turn might lead to structural changes
M AN U
117
in the choroid. Several studies have now shown significant decrease in choroidal thickness in smokers.100, 101, 111 These studies proposed reduction in choroidal thickness caused by smoking to be related to vascular dysfunction caused by decrease in nitric oxide bioavailability. This leads to
TE D
peripheral vasoconstriction, causing an increase in the peripheral resistance to flow and thereby a decrease in choroidal thickness.
EP
6. CHOROIDAL THICKNESS IN SYSTEMIC INFLAMMATORY CONDITIONS
AC C
Systemic inflammatory conditions may affect the ocular tissues and result in choroidal changes that often relate to the disease activity. Choroidal changes in such inflammatory conditions are demonstrated in Figure 2.
6.1. Ankylosing Spondylitis
14
ACCEPTED MANUSCRIPT
Ankylosing spondylitis is a chronic inflammatory disease that may also involve the eye, causing anterior uveitis. Uveitis is one of the classification criteria for seronegative spondyloarthritis and is its most common extra-articular manifestation. To date, only one study63
RI PT
was done to determine the effect of ankylosing spondylitis on the choroid. They studied 168 eyes of 84 ankylosing spondylitis patients and 126 eyes of 63 healthy subjects and found that
choroidal thickness was increased. There was, however, no correlation between choroidal
SC
thicknesses and the severity or duration of ankylosing spondylitis. The inflammation of the uveal tract may explain the increase in choroidal thickness . Choroidal thickness may, therefore, be a
which uveitis may develop.
TE D
6.2. Raynaud Phenomenon
M AN U
good indicator of ankylosing spondylitis disease activity and could help in identifying cases in
Raynaud phenomenon is a reversible vasospastic response of the extremities to cold or emotion and is a recognized early manifestation of systemic sclerosis. The effect on vasodilation
EP
and vasoconstriction is not limited to skin in the peripheries, but also is known to affect other organs, like the choroidal plexus of the eye. A study50 was done, involving 30 patients without
AC C
visual symptoms, classified as primary Raynaud phenomenon, Raynaud phenomenon secondary to suspected systemic sclerosis, and overt systemic sclerosis, and 27 normal subjects. In patients with primary Raynaud phenomenon, a thinning of choroidal thickness was observed. The thinning is more severe in Raynaud phenomenon secondary to suspected systemic sclerosis and in overt systemic sclerosis. Perhaps the thinning of choroid in Raynaud phenomenon is reflection of the systemic hemodynamic changes. The effect of blood circulation in Raynaud phenomenon 15
ACCEPTED MANUSCRIPT
has also been investigated and it has an association with basal sympathetic tone, also it has a higher incidence in women.23 Altered choroidal thickness once again may be an index of
RI PT
systemic blood circulation.
6.3. Vogt-Koyanagi-Harada Syndrome
SC
Vogt-Koyanagi-Harada (VKH) syndrome is a multi-systemic, autoimmune,
granulomatous inflammatory disease affecting the melanocyte-containing tissues such as the
M AN U
uvea, ear, skin and meninges. In the eye, VKH causes bilateral granulomatous panuveitis initially presenting as diffuse choroiditis with multifocal serous detachments that may result in serous retinal detachment. In the later stages of the disease, there is chorioretinal depigmentation, sunset glow fundus, or perilimbal vitiligo.88 There are 4 phases of the disease: prodromal, acute uveitis,
TE D
convalescent, and chronic-recurrent phases.
In 8 patients with active VKH syndrome, EDI-OCT measurements found that their mean
EP
choroidal thickness was 805 ± 173 µm, which is much thicker than in normal eyes.72 The choroidal thickness decreased in response to corticosteroid treatment to 341 ± 70 µm by the
AC C
fourteenth day.
Takashi et al105 studied one randomly selected eye from 19 patients with VKH syndrome
of duration more than 3 years, of which 12 eyes had severe sunset glow fundus and 7with little or no depigmentation. The mean choroidal thickness of the 12 eyes with severe sunset glow fundus was 144 ± 72µm, which was significantly thinner than that of the 7 eyes with little or no
16
ACCEPTED MANUSCRIPT
depigmentation. It was found that choroidal thickness was inversely correlated with disease duration and the degree of depigmentation.
RI PT
Similarly, a prospective case-control study25 was conducted on 16 patients (30 eyes) with VKH syndrome for more than 6 months and 17 normal individuals (32 eyes). Their eyes were examined by the EDI-OCT, and choroidal thickness was correlated to disease duration, clinical
SC
disease activity, and severity. The mean subfoveal choroidal thickness in the control group was 333µm (±85.8), compared to 250.7µm (±93.3) in VKH patients. Choroidal thickness was
thickness and disease duration.
M AN U
significantly decreased in patients with VKH, with a negative correlation between choroidal
These studies demonstrate an increase in choroidal thickness during periods of active
TE D
inflammation and a reduction during the chronic phase (Figure 3). Choroidal thickness measurement may be a noninvasive tool to monitor disease activity and guide treatment
EP
decisions.
AC C
6.4. Behçet Disease
Behçet disease is an idiopathic, multisystem disease characterized by recurrent orogenital
ulceration and vasculitis involving small, medium, and large veins and arteries. Ocular complications occur in 95% of men and 70% of women. It usually presents bilaterally and can cause acute panuveitis, retinitis, retinal vasculitis, and vitritis. End-stage disease is marked by vascular occlusion, optic atrophy and gliotic sheathing.81
17
ACCEPTED MANUSCRIPT
In 30 patients with Behçet disease, the mean subfoveal choroidal thickness in affected eyes was significantly greater in the acute phase of disease as compared to the quiescent phase (398.77 ± 155.59µm versus 356.72 ± 141.09µm).61 Even during the quiescent phase, the
RI PT
choroidal thickness in affected eyes was thicker in patients with Behçet disease compared to the general population (259.96 ± 65.16µm). Interestingly, the uninvolved eye in patients with Behçet disease also had a greater choroidal thickness as compared to the general population, suggesting
SC
that there may be choroidal infiltration even in the clinically uninvolved eye. A second study52 conducted on 23 eyes of 13 patients similarly observed a dilation of choroidal vessels during the
M AN U
active phase of uveitis, with the choroidal thickness being significantly greater than when the disease was in remission. Also, the choroidal thickness was significantly reduced after treatment with infliximab. Iccarino et al48 confirmed these results, with 23.3% of the 30 eyes from 15 patients having no increase in choroidal thickness and 76% with an increase in choroidal
TE D
thickness.
In contrast, another study24 on 35 patients with Behçet disease found that choroidal
EP
thickness was significantly reduced as compared to normal controls. This difference may be explained by the disease duration. In the first 2-3 years of Behçet disease, there is progressive
AC C
fibrosis and thinning of choroid due to ischemic changes in the choroid from the recurrent inflammation.
6.5. Sarcoidosis
18
ACCEPTED MANUSCRIPT
Sarcoidosis is a multi-systemic T-cell mediated granulomatous inflammatory disorder of unknown cause. There is a wide spectrum of disease, potentially affecting the mediastinal and superficial lymph nodes, lungs, liver, spleen, skin, parotid glands, pharyngeal bones and the eye.
RI PT
In the eye, it has variable manifestations as anterior, intermediate, or panuveitis. Choroidal and optic disc granulomas, multifocal choroiditis, and segmental and rarely occlusive phlebitis may
SC
also be seen.
Only isolated case reports havdescribe the imaging of choroid and assessment of choroid
M AN U
involvement in sarcoidosis. In the first study,79 the eye of a 63-year-old female with biopsyproven sarcoidosis was examined with EDI-OCT. She presented with unilateral multifocal choroidal granuloma, which was seen as a homogenous hyporeflective lesion with choriocapillaris thinning. The surrounding choroid was spared. The choroidal granulomas
TE D
decreased in size after treatment with immunosuppressive agents.
In a second case study,92 a 49-year-old woman with a choroidal granuloma secondary to
EP
sarcoidosis, the choroidal granuloma appeared as a localized hyporeflective choroidal thickening. The choroidal thickness decreased after 2 weeks of systemic corticosteroid treatment from
AC C
568µm to 356µm; after 5 months it decreased to 274µm and after 11 it reached 150µm.
7. CHOROIDAL THICKNESS IN TUMORS
7.1. Metastasis
19
ACCEPTED MANUSCRIPT
The choroid is the most common site for uveal metastases, accounting for approximately 90%, followed by the iris and ciliary body. The most common primary site is breast, followed by bronchus. Other possible primary sites are the gastrointestinal tract, kidney, skin melanoma
RI PT
and, rarely, the prostate. Metastasis to the choroid may occur unilaterally or bilaterally, and may be multifocal or unifocal. As such, unlike other systemic diseases, choroid metastases do not cause generalized increase or decrease in choroidal thickness. Shields et al99 examined 520 eyes
SC
and found that most metastatic choroid tumors are dome or plateau shaped and measured 3mm thick. The tumors were differentiated according to their primary sites, and it was found that the
M AN U
choroidal metastatic tumors from breast cancer are usually bilateral and multifocal, with a flatter tumor of 2mm at the thickest tumor focus. Thicker tumors were more often found in lung, gastrointestinal, kidney and prostate cancers, with the mean thickness in gastrointestinal and kidney cancers being 4mm. Metastatic tumors from skin melanomas were the flattest, with a
TE D
mean thickness of 1mm. A study5 that aimed to describe imaging features of choroidal metastasis using EDI-OCT examined 31 eyes with choroidal metastasis and found that the tumor has a characteristic “lumpy bumpy” anterior surface, with outer retina layer disruption, but
EP
preservation of inner layers of the retina. It also found that the choroidal metastases had an average thickness of 987µm. The conclusion of the study was that SD EDI-OCT allows
AC C
visualization and imaging of choroid metastases.
The appearance of choroid in hemangioma and metastasis is demonstrated in Figures 4, 5
and 6.
7.2. Sturge-Weber Syndrome 20
ACCEPTED MANUSCRIPT
Sturge-Weber syndrome (SWS) involves congenital hamatomatous malformations that affect the eye, central nervous system and eye . The most prevalent ocular malformation is the choroidal hemangioma, which usually enlarges slowly and affects over half of the choroid.
RI PT
Diffuse choroidal hemangiomas occur almost exclusively in patients with SWS andassociated with serous retinal detachment. This disease is known to cause an increase in choroidal thickness
SC
due to the vascular malformations.
An 18-year-old Caucasian boy with a known diagnosis of SWS had diffuse choroidal
M AN U
hemangiomas and serous retinal detachment treated with photodynamic therapy (PDT).15 OCT examinations were done at baseline and 3 and 12 months after PDT. The subfoveal choroidal thickness showed a reduction in thickness from 251 to 83µm post PDT. Thus, choroidal thickness measurement might be a beneficial parameter to follow the response to treatment for
TE D
patients with diffuse choroidal hemangiomas.
EP
8. CHOROIDAL THICKNESS IN HEMATOLOGICAL DISEASES
AC C
8.1. Sickle Cell Disease
Sickle cell disease (SCD) is caused by abnormal hemoglobins, which cause the red blood
cells to assume an abnormal shape. This is characterized by the presence of mutant hemoglobin S. Because of their abnormal shape, the red blood cells may cause vaso-occlusion, producing tissue hypoxia and ischemia.89 Sickle cell disease can cause either proliferative or nonproliferative sickle cell retinopathy.
21
ACCEPTED MANUSCRIPT
A study conducted on 208 eyes of 107 patients referred for screening of SCD.3 found that choroidal thickness was significantly decreased in patients with sickle cell disease as compared to age, gender, and ethnicity matched controls. This may be to the result of the slower blood flow
RI PT
in the choriocapillaris because of the sickling of the red blood cells. Interestingly, there was no difference in choroidal thickness between eyes in patients with sickle cell disease eyes with and
independent of changes in the choroidal circulation.
M AN U
8.2. Leukemia
SC
without macular thinning. This indicates that micro-arteriolar occlusions in the macula are
Leukemia is the disease of the hematopoietic stem cells, causing abnormal proliferation of white blood cells. Ocular involvement may occur in virtually any part of the eye, and it is
TE D
more common in acute than in chronic leukemias. Primary leukemic infiltration is rare and must be differentiated from the chronic sequelae of the disease in the form of anemia, thrombocytopenia, hyperviscosity and opportunistic infections. Choroidal deposits may occur,
EP
and present with a ‘leopard skin’ appearance.
AC C
The effect of leukemia on choroidal thickness has not been extensively studied, possibly because of the many other secondary complications that would affect results. One52-year-old man newly diagnosed with acute lymphocytic leukemia had EDI-OCT imaging th at showed diffuse choroidal thickening in both eyes, with subfoveal choroidal thickness being 500 and 503µm for the right and left eye respectively. 9 After 4 weeks of systemic chemotherapy, there was a marked decrease in choroidal thickness bilaterally (315 and 325µm). This suggests that 22
ACCEPTED MANUSCRIPT
choroidal thickness measurements could be a noninvasive tool to monitor disease activity and treatment outcomes in patients with leukemia; however, since this is only one case report.
RI PT
9. CHOROIDAL THICKNESS IN NEUROLOGICAL DISEASES
SC
9.1. Alzheimer Disease
Cerebral vascular impairment is one of the earliest pathological features in Alzheimer
M AN U
disease12, 28 and recent studies have speculated that retinal vasculature changes shows similar pathogenetic alterations as cerebral vasculature.13, 36 One prospective study39 involving 42 eyes of 21 patients with a diagnosis of mild to moderate Alzheimer disease, and 42 eyes of 21 agematched normal subjects showed that choroidal thickness was significantly decreased in
TE D
Alzheimer disease (p
